Corporate governance


Audit Committee

Mr Vikas Sinha
Dr David Ebsworth
Dr Andrew Sinclair

Remuneration Committee

Dr Ken Cunningham
Dr David Ebsworth
Mr Rishi Gupta

Nominations Committee

Dr David Ebsworth
Dr Mahendra Shah
Dr Anders Ullman

Corporate social responsibility

The Board of Directors of Verona Pharma recognises the importance of sound corporate governance and strives, where practicable for a company of its size and nature, to comply with the standards of good practice prescribed by the UK Corporate Governance Code (2012) in its four specified areas:

  • Board leadership and effectiveness
  • Directors' remuneration
  • Accountibility with respect to financial practices
  • Relations with shareholders

For a copy of the UK Corporate Governance Code (2012), visit the UK Financial Reporting Council (FRC) website at

The Board of Directors has established an Audit Committee, a Remuneration Committee and a Nominations and Corporate Governance Committee, with formally delegated duties and responsibilities.


Share dealing code

The Company has adopted a share dealing code in order to ensure compliance with the EU Market Abuse Regulation and Rule 21 of the AIM Rules.

Code of business conduct and ethics

The Company has adopted a code of business conduct and ethics in order to ensure compliance with the UK Bribery Act (2010) and as the Company’s “code of ethics” within the meaning of the Sarbanes-Oxley Act (2002).

AIM Rules compliance policy

The Company has adopted an AIM Rules compliance policy in order to ensure compliance with Rule 31 of the AIM Rules.

Policies and procedures for complaints

The Company has adopted policies and procedures for complaints regarding accounting, internal accounting controls, fraud and auditing matters. The Board has appointed a "compliance officer" to oversee compliance with the policies and procedures.

Financial performance

Date Title Downloads

Investor Presentation, February 2018

Investor Presentation, January 2018

Q3 2017 Report

Interim report 2017

Financial calendar

Annual General meeting

April 12, 2017 12:00 PM UKT – 6th Floor, 60 Gracechurch Street, London EC3V 0HR


Release of Interim Results for Six Months Ended June 30, 2017

August 8, 2017 from 8:00 AM to 11:55 AM EDT